What Biomed Diagnostics does

Biomed Diagnostics, founded in 1989 and operating as a brand under parent company DCN Dx (Diagnostic Consulting Network, LLC), designs and sells self-contained culture-based diagnostic devices for clinical, veterinary, and food and environmental microbiology laboratories. Its core platforms are the InTray® sealed cassette system, which integrates specimen collection, selective media incubation, and direct microscopic analysis, and the InPouch® resealable system, which combines sample collection, transport, incubation, and observation in a single contamination-resistant device. Around these platforms the company has built a deep product catalog of chromogenic COLOREX™ media formulations for pathogen-specific detection (MRSA, Salmonella, Listeria, E. coli O157, VRE, ESBL, KPC, GBS, Candida, UTI, dermatophytes), trichomonad detection products for human and animal use (InPouch TV, TF-Bovine, TF-Feline, TG/G), the BHBCheck Plus meter and test strips for bovine blood ketone and glucose monitoring, iClean® nasopharyngeal swabs, and supporting consumables and reference materials. Quantified performance claims include 94.7% sensitivity and 100% specificity for InPouch TV Trichomonas detection and 24-hour presumptive UTI identification with InTray COLORM Screen.

The business sells primarily through a direct account-based e-commerce storefront at biomeddiagnostics.com and complements this with an authorized international distributor network for global reach, targeting mid-market hospitals, clinical laboratories, veterinary practices, food processors, and environmental testing operations. Pricing is per-unit and gated behind account registration, with sample evaluation kits available for select products; there is no subscription or recurring revenue model. Marketing relies on the company website as a content hub, an email newsletter, industry conference participation (e.g., AAVLD 2024), and free product samples. Biomed Diagnostics is a small organization (11–50 employees) with no disclosed revenue, no venture funding, and no public listing, operating as a wholly-owned subsidiary within DCN Dx's broader IVD CDMO and CRO portfolio.

Name

Biomed Diagnostics

Legal name

Diagnostic Consulting Network, LLC

Website

https://biomeddiagnostics.com

Company type

Private

Founded year

1989

Operating status

Operating

Headcount range

11–50 employees

Short description

Biomed Diagnostics designs and sells self-contained InTray® and InPouch® culture-based diagnostic devices and chromogenic media for clinical, veterinary, and food/environmental laboratories worldwide, operating as a brand under parent DCN Dx.

Ownership category

akta.pro rank

Product category

Microbiology Diagnostics

NAICS

In-Vitro Diagnostic Substance Manufacturing (325413), Medical Equipment and Supplies Manufacturing (3391), Analytical Laboratory Instrument Manufacturing (334516)

SIC

In Vitro & In Vivo Diagnostic Substances (2835), Surgical & Medical Instruments & Apparatus (3841), Laboratory Analytical Instruments (3826)

akta.pro primary industry

Laboratory & Point-of-Care Diagnostic Devices (Analyzers, Test Kits, Microscopy) (HLAMAFAI)

akta.pro secondary industries

Veterinary Microbiology & Infectious Disease Testing (Culture/PCR/Serology) (HLAMADAC), Surface Swab Testing & Contact Plate Sampling Services (AFALAEAC)

Keywords

• Microbiological culture media
• Diagnostic culture systems
• Veterinary diagnostic devices
• Chromogenic detection media
• Clinical microbiology products

Headquarters

HQ city

White City

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales

Revenue model

1. Diagnostic Products Sales: Biomed Diagnostics generates revenue through the sale of their self-contained culture diagnostic products including InTray and InPouch systems, chromogenic culture media, nasopharyngeal swabs, and blood ketone/glucose meters. Products are sold directly through their e-commerce platform and through a global distributor network.

Pricing tiers

Go-to-market motion2 records

Distribution channels2 records

Marketing channels4 records

Core offering

Biomed Diagnostics manufactures and sells self-contained culture-based diagnostic devices built around two proprietary platforms: InTray® sealed cassettes and InPouch® resealable pouches. These products integrate specimen collection, transport, selective media incubation, and microscopic observation into a single sealed device for clinical, veterinary, and food/environmental microbiology laboratories. The company also offers chromogenic COLOREX™ media variants for presumptive pathogen identification, the BHBCheck Plus meter for bovine blood ketone/glucose measurement, and iClean® nasopharyngeal swabs.

Product overview

Biomed Diagnostics is a diagnostic solutions company offering culture-based testing products organized around two core platform systems: InTray® and InPouch®. The InTray® platform consists of self-contained cassette devices combining specimen collection, selective media incubation, and direct microscopic observation for point-of-care and laboratory pathogen identification across clinical, veterinary, and food safety applications. The InPouch® platform provides resealable culture-based diagnostic systems for specimen collection, transport, incubation, and microscopic observation. Supporting these core platforms, Biomed offers specialized chromogenic media products (COLOREX™ line) for differential pathogen detection including MRSA, Salmonella, Listeria, E. coli O157, VRE, ESBL, KPC, GBS, Candida, and UTI pathogens; dermatophyte detection products (DM, SAB-FungID™); and trichomonad detection products (TV, TF-Bovine, TF-Feline, TG/G). The company also provides the BHBCheck Plus veterinary meter system for blood ketone and glucose measurement in bovine samples, iClean® nasopharyngeal swabs for specimen collection, and various consumables including saline solution and PBS buffer. Products fall into three main categories: Clinical Microbiology (human health diagnostics), Veterinary Microbiology (animal health testing), and Food & Environmental Microbiology (food safety and environmental testing).

Differentiator

Problem solved

Functional benefit

Brands

• InTray®: Self-contained culture system integrating specimen collection, selective media incubation, and direct microscopic analysis within a sealed cassette for point-of-care and laboratory use.
• InPouch®

Products and services

• InTray® Self-Contained Culture System A self-contained cassette culture system integrating specimen collection, selective media incubation, and direct microscopic analysis for point-of-care and laboratory pathogen identification. Sold to clinical, veterinary, and food safety laboratories.
• InPouch® Culture-Based Diagnostic System

Quantifiable outcome

• InPouch TV culture system achieved 94.7% sensitivity and 100% specificity for Trichomonas vaginalis diagnosis
• +2 more outcomes

Segments4 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

One partnership is on record.

• DCN DxcoreOthersBiomed Diagnostics is now part of DCN Dx (Diagnostic Consulting Network, LLC). DCN Dx is a global leader in IVD CDMO and CRO services, specializing in lateral flow assays and tailored assay systems. Biomed Diagnostics operates as a brand within the DCN Dx portfolio, continuing to support laboratories worldwide with culture diagnostic solutions while benefiting from DCN Dx's broader diagnostic expertise and resources.

Scale indicators1 record

Recent moves6 records

Expansion highlights5 records

Direct peers

• Hardy Diagnostics: Hardy Diagnostics manufactures prepared culture media and microbiology products for clinical, food, and veterinary labs. It is the closest direct competitor to Biomed Diagnostics in form factor, customer base, and product portfolio breadth, with comparable product lines in chromogenic and prepared media.
• Neogen Corporation: Neogen (now merged with 3M's Food Safety business) provides food safety diagnostics, animal genomics, and biosecurity products. Overlaps with Biomed's Food & Environmental Microbiology and Veterinary Microbiology segments, particularly in pathogen detection for food processing and livestock.
• CHROMagar: CHROMagar (acquired by BioMérieux) is the pioneer of chromogenic culture media technology. Its product line directly competes with Biomed's COLOREX™ chromogenic InTray family for MRSA, Salmonella, Listeria, E. coli O157, and Candida differentiation.
• Copan Diagnostics: Copan manufactures specimen collection and transport devices (eSwab, flocked swabs) and automation for microbiology labs. Biomed's iClean® nasopharyngeal swabs and self-contained InPouch® transport formats directly compete with Copan's product positioning.

Broad incumbents

• bioMérieux: bioMérieux is a global leader in clinical and industrial microbiology, with deep portfolios in culture media, chromogenic identification, and antimicrobial susceptibility testing. It competes with Biomed across most clinical microbiology segments and dwarfs it in scale.
• BD (Becton, Dickinson and Company): BD Diagnostic Systems offers culture media, identification systems, and microbiology lab automation. Its broad product portfolio overlaps with Biomed's clinical microbiology products, particularly for hospital and reference lab customers.
• Thermo Fisher Scientific (Microbiology): Thermo Fisher supplies culture media, biochemical identification, and microbiology instrumentation through brands like Remel and Oxoid. It competes with Biomed across clinical and food safety microbiology segments at much larger scale.
• IDEXX Laboratories: IDEXX is the dominant player in companion animal diagnostics, with veterinary reference labs and in-clinic instruments. It is a relevant comparable for Biomed's veterinary microbiology products (especially feline/bovine/avian trichomonad testing) given customer overlap.
• Zoetis: Zoetis is the world's largest animal health company, with diagnostics (Vetscan, reference labs) plus pharmaceuticals. It is a relevant peer for Biomed's veterinary diagnostics products targeting livestock and companion animal health.

Emerging players

• R&F Products: R&F Products specializes in chromogenic culture media for pathogen identification (similar to Biomed's COLOREX line). A smaller specialty competitor focused on differentiation through chromogenic substrate technology in clinical and food microbiology applications.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xx.com/biomedtests
• Facebookfacebook.com/InPouch

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Biomed Diagnostics